Johnson Johnson
India  /  Published 03.06.21

Vaccine: Trial and test waiver

By G.S. Mudur in New Delhi

India  /  Published 28.05.21

Hope as govt clears Pfizer hurdle

By Reuters in New Delhi

India  /  Published 19.05.21

Indian firm to produce J&J shot

India’s Biological E. will produce the Johnson & Johnson Covid-19 vaccine alongside its own candidate, its managing director told Reuters on Tuesday, which could boost the country’s ov...
By Reuters in New Delhi

World  /  Published 10.05.21

Vaccine: US states pass up doses

Several states are turning away Covid vaccine doses from their federal government allocations, as the daily average of coronavirus vaccine doses administered across the US has fallen below two million...
By Giulia McDonnell, Nieto del Rio

World  /  Published 25.04.21

Johnson & Johnson Covid jab to resume

Use of the one-shot Johnson & Johnson Covid vaccine will resume within days, but with a warning added to its label about the risk for a rare blood-clotting disorder that has occurred among young w...
By Denise Grady, Julie Bosman and Noah Weiland


India  /  Published 20.04.21

J&J seeks nod for vaccine trial in India

Global healthcare major Johnson & Johnson on Tuesday said it has sought approval from India's drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the cou...
By Our Bureau, Agencies in New Delhi

India  /  Published 09.04.21

J&J: talks on for vaccine trials in India

  Global healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Fri...
By Our Bureau, Agencies in New Delhi

World  /  Published 01.03.21

US approval for Johnson vaccine

The US Food and Drug Administration on Saturday authorised Johnson & Johnson’s single-shot Covid-19 vaccine for emergency use, beginning the rollout of millions of doses of a third effective...
By Noah Weiland, Sharon LaFraniere in Washington

World  /  Published 14.10.20

Vaccine: volunteer’s illness halts trials

Johnson & Johnson has paused the large late-stage clinical trial of its coronavirus vaccine because of an “unexplained illness” in one of the volunteers, the company said on Monday. T...
By New York Times News Service in New York

World  /  Published 24.09.20

Vaccine: J&J in last lap

Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify distribution of millions of doses compared with leading riva...
By Reuters in Chicago


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.